OraSure Technologies Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
93,191.00
97,867.00
101,319.00
120,950.00
155,897.00
156,572
Total Accounts Receivable
12,957.00
16,138.00
19,265.00
19,827.00
42,521.00
34,842
Inventories
11,444.00
15,763.00
13,242.00
11,799.00
19,343.00
22,888
Other Current Assets
1,983.00
1,446.00
2,888.00
3,865.00
4,144.00
5,010
Total Current Assets
119,575.00
131,214.00
136,714.00
156,441.00
221,905.00
219,312
Net Property, Plant & Equipment
17,933.00
17,934.00
20,083.00
20,033.00
21,372.00
24,299
Total Investments and Advances
-
-
-
-
20,690.00
44,752
Intangible Assets
46,008.00
39,239.00
30,841.00
29,130.00
28,306.00
23,658
Other Assets
729.00
1,246.00
1,683.00
2,331.00
3,928.00
3,550
Total Assets
184,245.00
189,633.00
189,321.00
207,935.00
296,201.00
315,571
Accounts Payable
4,834.00
7,148.00
5,087.00
4,633.00
10,228.00
Income Tax Payable
-
139.00
-
-
6,469.00
Other Current Liabilities
14,151.00
19,175.00
20,147.00
12,702.00
15,540.00
Total Current Liabilities
18,985.00
26,462.00
25,234.00
17,335.00
32,237.00
Provision for Risks & Charges
677.00
1,234.00
-
-
-
Deferred Taxes
3,437.00
3,236.00
2,883.00
2,446.00
1,951.00
Other Liabilities
-
-
1,768.00
2,304.00
3,932.00
Total Liabilities
23,099.00
30,932.00
29,885.00
22,085.00
38,120.00
Common Equity (Total)
161,146.00
158,701.00
159,436.00
185,850.00
258,081.00
Total Shareholders' Equity
161,146.00
158,701.00
159,436.00
185,850.00
258,081.00
Total Equity
161,146.00
158,701.00
159,436.00
185,850.00
258,081.00
Liabilities & Shareholders' Equity
184,245.00
189,633.00
189,321.00
207,935.00
296,201.00

About OraSure Technologies

View Profile
Address
220 East 1st Street
Bethlehem Pennsylvania 18015
United States
Employees -
Website http://www.orasure.com
Updated 07/08/2019
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices.